NEW YORK, May 13, 2023 (GLOBE NEWSWIRE) —

CTI BioPharma Corp CTIC

Lifshitz Law PLLC announces an investigation into a possible breach of fiduciary duty in connection with the sale of CTIC to Swedish Orphan Biovitrum AB for $9.10 per share in cash.

If you are a CTIC investor and would like more information about our research, please fill out the form Information request form or contact Joshua Lifshitz, Esq. by calling (516)493-9780 or emailing info@lifshitzlaw.com.

arconic corp ARNC

Lifshitz Law PLLC announces an investigation into a possible breach of fiduciary duty in connection with the sale of ARNC to Apollo Global Management, Inc. for $30.00 per share in cash.

If you are an ARNC investor and would like more information about our research, please fill out the form Information request form or contact Joshua Lifshitz, Esq. by calling (516)493-9780 or emailing info@lifshitzlaw.com.

Amedisys Inc. AMEED

Lifshitz LAw PLCC Announces investigation into a possible breach of fiduciary duty in connection with the merger of AMED and Option Care Health, Inc. whereby AMED shareholders will receive 3.0213 shares of Option Care Health for every share of AMED.

If you are an AMED investor and would like more information about our research, please fill out the form Information request form or contact Joshua Lifshitz, Esq. by calling (516)493-9780 or emailing info@lifshitzlaw.com.

Option Care Health, Inc. OPCH

Lifshitz Law PLLC announces an investigation into a possible breach of fiduciary duties in connection with the OPCH-Amedisys Inc. merger. Post-merger, OPCH shareholders are expected to own approximately 64.5% of the combined company’s outstanding equity prior to the merger.

If you are an OPCH investor and would like more information about our research, please fill out the form Information request form or contact Joshua Lifshitz, Esq. by calling (516)493-9780 or emailing info@lifshitzlaw.com.

ATTORNEY ADVERTISING.©…